Proton Pump Inhibitors – New warning
October 24, 2016 – The FDA approved new updates to the Warnings and Precautions section of the drug labels for the proton pump inhibitors (PPIs), pertaining to serious cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE).
Download PDF
